Menorrhagia, or heavy menstrual bleeding (HMB), is a common presenting complaint, accounting for 5% of female primary care consultations and 20% of gynaecology clinic consultations every year. The majority of these patients can be managed competently in primary care, referring patients requiring surgical intervention or those with suspected malignancy to secondary care. This article will explore the diagnosis and management of women presenting with HMB in primary care in accordance with guidelines from the National Institute for Health and Care Excellence (NICE) and the RCGP curriculum.
LeminenHHurskainenR (2012) Tranexamic acid for the treatment of heavy menstrual bleeding: Efficacy and safety. International Journal of Women’s Health4: 413–421. DOI: 10.2147/IJWH.S13840.
3.
MaybinJACritchleyHOD (2016) Medical management of heavy menstrual bleeding. Womens Health12(1): 27–34. DOI: 10.2217/whe.15.100.
NICE (2018b) Clinical knowledge summary: Uterine fibroids. Available at: https://cks.nice.org.uk/fibroids#!topicsummary (accessed 20 September 2018).
9.
PennantMEMehtaRMoodyPet al.(2016) Premenopausal abnormal uterine bleeding and risk of endometrial cancer. British Journal of Obstetrics and Gynaecology124(3): 404–411. DOI: 10.1111/1471-0528.14385.
